|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.70 EUR | -0.42% |
|
-4.82% | -1.25% |
| 02/06 | Bastide finalizes the sale of its EXPERF subsidiary | |
| 02/06 | France's Groupe Bastide Completes Sale of New Medical Concept Subsidiary | MT |
Company Valuation: Bastide Le Confort Médical
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 347 | 258 | 208.9 | 134.1 | 232.1 | 175.7 | - | - |
| Change | - | -25.65% | -19.05% | -35.8% | 73.08% | -24.31% | - | - |
| Enterprise Value (EV) 1 | 670.9 | 655.1 | 523.4 | 449.3 | 623 | 474.7 | 470.7 | 462.7 |
| Change | - | -2.36% | -20.1% | -14.16% | 38.66% | -23.81% | -0.84% | -1.7% |
| P/E ratio | 26x | 19x | 18.8x | -151x | 447x | 14.1x | 11.2x | 9.37x |
| PBR | 4.29x | 3.04x | 2.43x | 1.69x | 3.44x | - | - | - |
| PEG | - | 11.59x | -1x | 1x | -3x | 0x | 0.4x | 0.5x |
| Capitalization / Revenue | 0.78x | 0.55x | 0.41x | 0.25x | 0.47x | 0.34x | 0.33x | 0.31x |
| EV / Revenue | 1.51x | 1.4x | 1.03x | 0.85x | 1.27x | 0.93x | 0.87x | 0.81x |
| EV / EBITDA | 7.6x | 6.9x | 5.15x | 4.18x | 5.98x | 4.45x | 4.14x | 3.81x |
| EV / EBIT | 18.1x | 16.8x | 12.2x | 10x | 14.1x | 10.3x | 9.49x | 8.76x |
| EV / FCF | 24.1x | 183x | 10.1x | 12x | 14.9x | 18.5x | 16.2x | 13.6x |
| FCF Yield | 4.15% | 0.55% | 9.94% | 8.3% | 6.7% | 5.39% | 6.18% | 7.35% |
| Dividend per Share 2 | 0.27 | - | - | - | - | - | - | - |
| Rate of return | 0.57% | - | - | - | - | - | - | - |
| EPS 2 | 1.83 | 1.86 | 1.52 | -0.12 | 0.07 | 1.68 | 2.12 | 2.53 |
| Distribution rate | 14.8% | - | - | - | - | - | - | - |
| Net sales 1 | 444.1 | 468.3 | 508 | 529.8 | 491.2 | 510 | 540 | 571 |
| EBITDA 1 | 88.3 | 95 | 101.6 | 107.6 | 104.2 | 106.7 | 113.8 | 121.3 |
| EBIT 1 | 36.98 | 38.9 | 42.79 | 44.9 | 44.2 | 46 | 49.6 | 52.8 |
| Net income 1 | 13.45 | 13.68 | 12.05 | -0.9 | 0.528 | 12.6 | 15.9 | 19 |
| Net Debt 1 | 323.9 | 397.1 | 314.6 | 315.2 | 390.9 | 299 | 295 | 287 |
| Reference price 2 | 47.50 | 35.30 | 28.60 | 18.10 | 31.30 | 23.70 | 23.70 | 23.70 |
| Nbr of stocks (in thousands) | 7,306 | 7,309 | 7,303 | 7,408 | 7,415 | 7,412 | - | - |
| Announcement Date | 18/10/21 | 18/10/22 | 18/10/23 | 23/10/24 | 22/10/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.17x | 0.93x | 4.46x | -.--% | 20Cr | ||
| 39.92x | 0.94x | 17.38x | -.--% | 1.27TCr | ||
| 15.03x | 1.03x | 8.03x | -.--% | 169.49Cr | ||
| 27.77x | - | - | - | 113.93Cr | ||
| 7.86x | 0.85x | 4.47x | 6.08% | 6.53Cr | ||
| -1.68x | 0.11x | -3.22x | -.--% | 5.72Cr | ||
| Average | 17.18x | 0.77x | 6.22x | 1.22% | 264.67Cr | |
| Weighted average by Cap. | 35.78x | 0.95x | 15.99x | 0.03% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BLC Stock
- Valuation Bastide Le Confort Médical
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















